LBO — ATRIUM HEALTH ANSON
IRR: 23.3% | MOIC: 2.85x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
23.3%
IRR
2.85x
MOIC
$11.0M
Entry EV
$21.3M
Exit EV
$5.7M
Equity Invested
Sources & Uses
S&UTotal · $11.0M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $4.3M | 38.8% | |
| Sub Debt | $1.1M | 9.7% | |
| Equity | $5.7M | 51.5% | |
| Enterprise Value | $10.7M | 97.1% | |
| Transaction Fees | $0.3M | 2.9% | |
| Total Uses | $11.0M | 100.0% |
Interpretation
INTAt 2.85x MOIC and 23.3% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $2.0M |
| Exit Ev | $21.3M |
| Net Debt At Exit | $5.1M |
| Equity At Exit | $16.2M |
| Equity Invested | $5.7M |
| Total Value Created | $10.5M |
| Value From Growth | $10.0M |
| Value From Multiple | $0.5M |
| Value From Deleveraging | $0.2M |